GE HealthCare Technologies Inc. GEHC
GE HealthCare Technologies Inc. ("GE HealthCare," the "Company," "our," "us," or "we") is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits. Serving patients and providers for nearly 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalized, precise patient care. This is complemented by our broad service capabilities and dedication to quality and integrity with a strong operational culture, supported by our lean business system, Heartbeat.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $20.62B | $19.67B | $19.55B | $18.34B | $17.59B | — |
| Gross profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B | — |
| R&D | $1.26B | $1.31B | $1.21B | $1.03B | $816.0M | — |
| SG&A | $4.22B | $4.27B | $4.28B | $3.63B | $3.56B | — |
| Total operating expenses | $5.49B | $5.58B | $5.49B | $4.66B | $4.38B | — |
| Operating income | $2.76B | $2.62B | $2.44B | $2.52B | $2.79B | — |
| Pre-tax income | $2.77B | $2.58B | $2.36B | $2.51B | $2.88B | — |
| Income tax | $614.0M | $531.0M | $743.0M | $563.0M | $600.0M | — |
| Net income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B | — |
| EPS, basic | 4.56 | 4.37 | 3.05 | 4.22 | 4.95 | — |
| EPS, diluted | 4.55 | 4.34 | 3.03 | 4.22 | 4.95 | — |
| Shares, diluted (wtd. avg.) | $458.0M | $459.0M | $458.0M | $454.0M | $454.0M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $4.49B | $2.87B | $2.51B | $1.45B | $561.0M | $1.01B |
| Inventory | $2.23B | $1.94B | $1.96B | $2.15B | — | — |
| Total current assets | $12.50B | $9.90B | $9.41B | $8.32B | — | — |
| Property, plant and equipment | — | — | $2.14B | $2.00B | — | — |
| Goodwill | $13.49B | $13.14B | $12.94B | $12.81B | $12.89B | — |
| Other intangibles | $1.13B | $1.08B | $1.25B | $1.52B | — | — |
| Total assets | $36.91B | $33.09B | $32.45B | $27.54B | — | — |
| Accounts payable | $3.25B | $3.04B | $2.95B | $2.94B | — | — |
| Short-term debt | $502.0M | $1.50B | $1.00B | $15.0M | — | — |
| Total current liabilities | $9.11B | $9.55B | $8.98B | $7.19B | — | — |
| Long-term debt | $9.49B | $7.45B | $8.44B | $8.23B | — | — |
| Total liabilities | $26.31B | $24.44B | $25.14B | $17.95B | — | — |
| Retained earnings | $5.28B | $3.26B | $1.33B | $0 | — | — |
| Total equity | $10.38B | $8.45B | $7.14B | $9.36B | $16.68B | $14.75B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.99B | $1.96B | $2.10B | $2.13B | $1.61B | — |
| Depreciation and amortisation | $287.0M | $268.0M | $248.0M | $228.0M | $225.0M | — |
| Stock-based compensation | $130.0M | $125.0M | $114.0M | $67.0M | $76.0M | — |
| Capital expenditure | $482.0M | $401.0M | $387.0M | $310.0M | $248.0M | — |
| Investing cash flow | -$1.05B | -$914.0M | -$558.0M | -$398.0M | -$1.76B | — |
| Financing cash flow | $617.0M | -$573.0M | -$478.0M | -$822.0M | -$263.0M | — |
| Dividends paid | $64.0M | $55.0M | $41.0M | $0 | $0 | — |
| Buybacks | $200.0M | $0 | $0 | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001932393-26-000007.
Others in SIC 3844
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BFLY | Butterfly Network, Inc. | $1.93B | — | 19.0% |
| PHG | KONINKLIJKE PHILIPS NV | — | — | — |
| MBAI | Check-Cap Ltd | — | — | — |
| NNOX | Nano-X Imaging Ltd. | — | — | 15.4% |